JP2004502025A5 - - Google Patents

Download PDF

Info

Publication number
JP2004502025A5
JP2004502025A5 JP2002506748A JP2002506748A JP2004502025A5 JP 2004502025 A5 JP2004502025 A5 JP 2004502025A5 JP 2002506748 A JP2002506748 A JP 2002506748A JP 2002506748 A JP2002506748 A JP 2002506748A JP 2004502025 A5 JP2004502025 A5 JP 2004502025A5
Authority
JP
Japan
Prior art keywords
isolated compound
acetylneuraminic acid
formula
linkage
embedded image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002506748A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004502025A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/018219 external-priority patent/WO2002002127A1/en
Publication of JP2004502025A publication Critical patent/JP2004502025A/ja
Publication of JP2004502025A5 publication Critical patent/JP2004502025A5/ja
Pending legal-status Critical Current

Links

JP2002506748A 2000-07-03 2000-07-03 腫瘍関連抗原としての拡張i型スフィンゴ糖脂質鎖 Pending JP2004502025A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/018219 WO2002002127A1 (en) 2000-07-03 2000-07-03 Extended type 1 chain glycosphingolipids as tumor-associated antigens

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007096954A Division JP2007191490A (ja) 2007-04-02 2007-04-02 腫瘍関連抗原としての拡張i型スフィンゴ糖脂質鎖

Publications (2)

Publication Number Publication Date
JP2004502025A JP2004502025A (ja) 2004-01-22
JP2004502025A5 true JP2004502025A5 (enExample) 2006-01-05

Family

ID=21741553

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002506748A Pending JP2004502025A (ja) 2000-07-03 2000-07-03 腫瘍関連抗原としての拡張i型スフィンゴ糖脂質鎖

Country Status (6)

Country Link
EP (1) EP1307207A4 (enExample)
JP (1) JP2004502025A (enExample)
KR (1) KR100666238B1 (enExample)
CN (1) CN1291723C (enExample)
AU (2) AU6065200A (enExample)
WO (1) WO2002002127A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5331293B2 (ja) * 2006-04-28 2013-10-30 公益財団法人野口研究所 多様性を表現するオリゴ糖またはその誘導体
AU2008361352B2 (en) * 2008-09-07 2013-05-09 Glyconex Inc. Anti-extended Type I glycosphingolipid antibody, derivatives thereof and use
CN104655859B (zh) * 2013-11-21 2017-10-03 苏州中赢医疗科技有限公司 乳腺癌的诊断标志物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083929A (en) * 1991-05-06 2000-07-04 The Biomembrane Institute Extended type 1 chain glycosphingolipids as tumor-associated antigens
WO1992019634A1 (en) * 1991-05-06 1992-11-12 The Biomembrane Institute Extended type 1 chain glycosphingolipids as tumor-associated antigens

Similar Documents

Publication Publication Date Title
US5580858A (en) Immunosuppressive and tolerogenic modified Lewisx compounds
EP0589933B1 (en) Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides
Easton et al. Pregnancy-associated changes in the glycosylation of Tamm-Horsfall glycoprotein: expression of sialyl lewisx sequences on core 2 typeo-glycans derived from uromodulin
US8158763B2 (en) Sugar chain asparagine derivatives, sugar chain asparagine, sugar chain and processes for producing these
CA2418815A1 (en) Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
UCHIKAWA et al. Structural studies on teichoic acids in cell walls of several serotypes of Listeria monocytogenes
US6013779A (en) Process for preparation of glycosides of tumor-associated carbohydrate antigens
CA2110797C (en) Modified sialyl lewis x compounds
Campagnari et al. Use of pyocin to select a Haemophilus ducreyi variant defective in lipooligosaccharide biosynthesis
US20050038184A1 (en) Saccharide residue-functional corganopolysiloxanes and method for the preparation thereof
EP0344955A3 (en) Novel long-chain glycolipid structure
ATE356845T1 (de) Saccharide-enthaltende funktionelle organopolycarbosiloxane und verfahren zu deren herstellung
Neethling et al. The reducing end of αGal oligosaccharides contributes to their efficiency in blocking natural antibodies of human and baboon sera
JP2004502025A5 (enExample)
Abronina et al. The use of silyl groups in the synthesis of arabinofuranosides
JP2908558B2 (ja) 炭水化物のアクリル及びメタクリルコポリマー並びに該ポリマーの製造方法
CA2110582C (en) Modified sialyl lewis a compounds
CN1293679A (zh) 新的五糖及其制备方法和含有它们的药物组合物
US6060597A (en) Cyclic oligosaccharide, and an agent containing the same for preventing or treating retroviral diseases
JPH04502010A (ja) グリコサミノシルトランスフェラーゼvの阻害剤
CN1317053A (zh) 生产唾液酸化寡糖的方法
Matsumoto et al. Carbohydrates of influenza virus hemagglutinin: structures of the whole neutral sugar chains
JPH0816118B2 (ja) 抗ウイルス剤
JPH1025305A (ja) 分岐シクロデキストリンおよびその製造方法
WO1992022564A1 (en) Immunosuppressive and tolerogenic modified lewisx and lewisa compounds